HRTX
Price
$1.10
Change
-$0.02 (-1.79%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
205.37M
105 days until earnings call
Intraday BUY SELL Signals
LRMR
Price
$3.45
Change
+$0.06 (+1.77%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
289.72M
119 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HRTX vs LRMR

Header iconHRTX vs LRMR Comparison
Open Charts HRTX vs LRMRBanner chart's image
Heron Therapeutics
Price$1.10
Change-$0.02 (-1.79%)
Volume$72.93K
Capitalization205.37M
Larimar Therapeutics
Price$3.45
Change+$0.06 (+1.77%)
Volume$18.79K
Capitalization289.72M
HRTX vs LRMR Comparison Chart in %
HRTX
Daily Signal:
Gain/Loss:
LRMR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HRTX vs. LRMR commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRTX is a Hold and LRMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (HRTX: $1.12 vs. LRMR: $3.38)
Brand notoriety: HRTX and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HRTX: 120% vs. LRMR: 46%
Market capitalization -- HRTX: $199.87M vs. LRMR: $295.71M
HRTX [@Biotechnology] is valued at $199.87M. LRMR’s [@Biotechnology] market capitalization is $295.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRTX’s FA Score shows that 0 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • HRTX’s FA Score: 0 green, 5 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, LRMR is a better buy in the long-term than HRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRTX’s TA Score shows that 5 TA indicator(s) are bullish while LRMR’s TA Score has 4 bullish TA indicator(s).

  • HRTX’s TA Score: 5 bullish, 5 bearish.
  • LRMR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, HRTX is a better buy in the short-term than LRMR.

Price Growth

HRTX (@Biotechnology) experienced а -3.45% price change this week, while LRMR (@Biotechnology) price change was -6.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

HRTX is expected to report earnings on Mar 04, 2026.

LRMR is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LRMR($290M) has a higher market cap than HRTX($205M). LRMR YTD gains are higher at: -12.532 vs. HRTX (-26.797). HRTX has higher annual earnings (EBITDA): 7.54M vs. LRMR (-108.21M). LRMR has more cash in the bank: 139M vs. HRTX (40.6M). LRMR has less debt than HRTX: LRMR (4.61M) vs HRTX (177M). HRTX has higher revenues than LRMR: HRTX (150M) vs LRMR (0).
HRTXLRMRHRTX / LRMR
Capitalization205M290M71%
EBITDA7.54M-108.21M-7%
Gain YTD-26.797-12.532214%
P/E RatioN/AN/A-
Revenue150M0-
Total Cash40.6M139M29%
Total Debt177M4.61M3,836%
FUNDAMENTALS RATINGS
HRTX vs LRMR: Fundamental Ratings
HRTX
LRMR
OUTLOOK RATING
1..100
1266
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8455
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
6550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (19) in the null industry is somewhat better than the same rating for HRTX (71) in the Biotechnology industry. This means that LRMR’s stock grew somewhat faster than HRTX’s over the last 12 months.

LRMR's Profit vs Risk Rating (100) in the null industry is in the same range as HRTX (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to HRTX’s over the last 12 months.

LRMR's SMR Rating (100) in the null industry is in the same range as HRTX (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to HRTX’s over the last 12 months.

LRMR's Price Growth Rating (55) in the null industry is in the same range as HRTX (84) in the Biotechnology industry. This means that LRMR’s stock grew similarly to HRTX’s over the last 12 months.

LRMR's P/E Growth Rating (100) in the null industry is in the same range as HRTX (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to HRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HRTXLRMR
RSI
ODDS (%)
Bullish Trend 14 days ago
89%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
HRTX
Daily Signal:
Gain/Loss:
LRMR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BZQIF1.930.16
+8.95%
Bezeq The Israel Telecommunication Corp Ltd.
ALGGF0.12N/A
N/A
Alliance Global Group, Inc.
KNYJF67.21N/A
N/A
Kone Oyj
NGHI0.30N/A
N/A
New Green Hemp Inc.
ABSSF3.03-0.12
-3.81%
AirBoss of America Corp.

HRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with GSGTF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRTX
1D Price
Change %
HRTX100%
+2.75%
GSGTF - HRTX
45%
Loosely correlated
N/A
AMRN - HRTX
44%
Loosely correlated
+4.33%
CYCN - HRTX
42%
Loosely correlated
+2.16%
AXON - HRTX
38%
Loosely correlated
-1.74%
LGVN - HRTX
37%
Loosely correlated
-1.39%
More

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with OCUL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
-4.11%
OCUL - LRMR
43%
Loosely correlated
-1.09%
MLTX - LRMR
43%
Loosely correlated
+3.23%
ERAS - LRMR
42%
Loosely correlated
N/A
EYPT - LRMR
42%
Loosely correlated
+6.13%
AMLX - LRMR
42%
Loosely correlated
-0.21%
More